Inflammation

Items 31-40 of 166

per page
Set Descending Direction
  1. anti-Polyglutamylation Modification, mAb (GT335) (Biotin)
    AG-20B-0020B
    AG-20B-0020B-C100100 µg
    CHF 530.00
  2. anti-Profilin, pAb (IG-706)
    AG-25T-0117
    AG-25T-0117-C01010 µg
    CHF 350.00
  3. anti-PSD-95 (palmitoylated), mAb (rec.) (PF11)
    AG-27B-0021
    AG-27B-0021-C100100 µg
    CHF 455.00
    Palmitoylated PSD95 is detected by immunocytochemistry using anti-PSD-95 (palmitoylated), mAb (rec.) (PF11) (Prod. No AG-27B-0021). Method: HeLa cells were cotransfected with DHHC2 (palmitoylating enzyme) + PSD95-GFP (A) or DHHC2 (palmitoylat
  4. anti-Sortilin (human), mAb (rec.) (blocking) (preservative free) [Latozinemab]
    AG-27B-7000PF
    AG-27B-7000PF-C100100 µg
    CHF 420.00
    AG-27B-7000PF-C500500 µg
    CHF 1'600.00
    anti-Sortilin (human), mAb (rec.) (blocking) (preservative free) [Latozinemab]
  5. Antipain . dihydrochloride
    CAS  37682-72-7
    AG-CP3-7002
    AG-CP3-7002-M0055 mg
    CHF 45.00
    AG-CP3-7002-M02525 mg
    CHF 170.00
    Antipain . dihydrochloride
  6. Arginase I (human) (rec.) (highly active)
    AG-40T-0124
    AG-40T-0124-C01010 µg
    CHF 270.00
    AG-40T-0124-30103 x 10 µg
    CHF 675.00
    Arginase I (human) (rec.) (highly active)
  7. Ascomycin (high purity)
    CAS  104987-12-4
    AG-CN2-0420
    AG-CN2-0420-M0011 mg
    CHF 30.00
    AG-CN2-0420-M0055 mg
    CHF 60.00
    AG-CN2-0420-M02525 mg
    CHF 160.00
    Ascomycin (high purity)
  8. Asialo-Ganglioside GM1
    CAS  71012-19-6
    AG-CN2-9008
    AG-CN2-9008-C500500 µg
    CHF 240.00
    AG-CN2-9008-M0011 mg
    CHF 410.00
    Asialo-Ganglioside GM1
  9. Asialo-Ganglioside GM2
    CAS  35960-33-9
    AG-CN2-9009
    AG-CN2-9009-C100100 µg
    CHF 300.00
    Asialo-Ganglioside GM2
  10. Asiatic acid
    CAS  464-92-6
    AG-CN2-0400
    AG-CN2-0400-M0055 mg
    CHF 60.00
    AG-CN2-0400-M02525 mg
    CHF 240.00
    Asiatic acid

Items 31-40 of 166

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.